Bristol-Myers Squibb Company (BMY) Profit Margins
Over the twelve months to 2026-06-30, Bristol-Myers Squibb Company (BMY) had gross margin 70.2%, net margin 18.9%, free cash flow margin 23.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BMYBristol-Myers Squibb CompanyFollow BMY — free
—
Price chart with a free account
- Market cap
- 125.6B
- P/E TTM
- 13.5
- Dividend yield
- 4.1%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 72.7% | 72.9% | 73.6% | 73.8% | 71.8% | 75.2% | 76.4% | 74.5% | 70.7% | 71.3% | 69.1% | 72.3% | 78.6% | 78.0% | 76.2% | 71.1% | 71.1% | 70.2% | |
| Net margin | 56.4% | 15.9% | 17.5% | 11.1% | 15.6% | 12.6% | 9.5% | 22.9% | 4.8% | 21.8% | 13.2% | -21.2% | 15.1% | 13.7% | 17.8% | -18.5% | 14.6% | 18.9% | |
| FCF margin | 17.7% | 20.9% | 21.1% | 36.3% | 18.4% | 16.5% | 7.8% | 9.5% | 20.3% | 27.1% | 28.2% | 31.3% | 32.8% | 25.9% | 28.1% | 28.9% | 26.7% | 23.3% |
USD billions · SEC XBRL
Bristol-Myers Squibb Company — questions
- What is Bristol-Myers Squibb Company's gross margin?
- 70.2% over the twelve months to 2026-06-30.
- What is Bristol-Myers Squibb Company's net profit margin?
- 18.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Bristol-Myers Squibb Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.